Latest Annexin Pharmaceuticals News & Updates

See the latest news and media coverage for Annexin Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Annexin Pharmaceuticals

Clinical-stage biotechnology company developing Annexin A5 therapeutics

annexinpharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Annexin Pharmaceuticals

In short: Annexin Pharmaceuticals advanced its ANXV candidate for retinal diseases, expanded clinical trials into Germany, and secured multiple rights issues.

Company announcements

Annexin Pharmaceuticals

Annexin Pharmaceuticals secures bridge loan and plans rights issue

They obtain a SEK 4 million bridge loan and plan a SEK 20 million rights issue to fund Phase 2a NEXUS; major shareholders committed about SEK 12 million.

Unlock all announcements with a

Media coverage

Barron's

Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale...

Dagens industri

Annexin receives approval for clinical trial in Germany

Annexin Pharmaceuticals has received approval for a clinical trial with the drug candidate ANXV from the German drug authority Bundesinstitut...

Unlock all articles with a

Never miss news about Annexin Pharmaceuticals

Track Annexin Pharmaceuticals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Annexin Pharmaceuticals competitors & trending companies

Browse news for competitors to Annexin Pharmaceuticals and other trending companies.